Reccardini, N.; Chernovsky, M.; Salton, F.; Confalonieri, P.; Mondini, L.; Barbieri, M.; Romallo, A.; Maggisano, M.; Torregiani, C.; Geri, P.;
et al. Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-World Observation on Efficacy and Safety, Focus on Patients Undergoing Antithrombotic and Anticoagulant. Pharmaceuticals 2024, 17, 930.
https://doi.org/10.3390/ph17070930
AMA Style
Reccardini N, Chernovsky M, Salton F, Confalonieri P, Mondini L, Barbieri M, Romallo A, Maggisano M, Torregiani C, Geri P,
et al. Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-World Observation on Efficacy and Safety, Focus on Patients Undergoing Antithrombotic and Anticoagulant. Pharmaceuticals. 2024; 17(7):930.
https://doi.org/10.3390/ph17070930
Chicago/Turabian Style
Reccardini, Nicolò, Maria Chernovsky, Francesco Salton, Paola Confalonieri, Lucrezia Mondini, Mariangela Barbieri, Antonio Romallo, Marta Maggisano, Chiara Torregiani, Pietro Geri,
and et al. 2024. "Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-World Observation on Efficacy and Safety, Focus on Patients Undergoing Antithrombotic and Anticoagulant" Pharmaceuticals 17, no. 7: 930.
https://doi.org/10.3390/ph17070930
APA Style
Reccardini, N., Chernovsky, M., Salton, F., Confalonieri, P., Mondini, L., Barbieri, M., Romallo, A., Maggisano, M., Torregiani, C., Geri, P., Hughes, M., Campochiaro, C., Confalonieri, M., Scarda, A., Zuccon, U., & Ruaro, B.
(2024). Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-World Observation on Efficacy and Safety, Focus on Patients Undergoing Antithrombotic and Anticoagulant. Pharmaceuticals, 17(7), 930.
https://doi.org/10.3390/ph17070930
